- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01089842
Health Coaching to Promote Physical Activity for Coronary Heart Disease Prevention
Randomized Clinical Trial to Assess the Efficacy and Cost-efficacy of Health Coaching to Promote Physical Activity in Secondary Prevention of Coronary Heart Disease
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Cardiovascular diseases are the main cause of death in developed countries. Epidemiological studies have shown that a sedentary lifestyle is associated with an increased risk of cardiovascular diseases, mainly related to classical risk factors (obesity, diabetes, hypertension). International guidelines recommend, because of that, a minimum of 30 minutes per day at least 5 days per week of moderate physical activity for primary and secondary cardiovascular disease prevention.
Physical inactivity is an increasing public health problem in developed countries. It is known that clinical advice has a poor efficacy to increase levels of physical activity on individuals and new strategies need to be developed.
Coaching is a strategy of personal help that is being widely and successfully used in business world. It consists of an structured and individualized process of assistance to people to promote cognitive changes needed to achieve behavioural changes. It can be a complementary method to information and sanitary education emphasizing on consciousness and responsibility of the patient and is now starting to be used in medical practice. The purpose of the study is to define usefulness of an strategy based on coaching techniques to promote physical activity practice and healthy lifestyle on individuals with known coronary heart disease or cardiovascular risk factors.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Barcelona
-
Sabadell, Barcelona, Spain, 08208
- Recruiting
- Hospital de Sabadell
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients wiht coronary risk factors or known ischaemic heart disease defined as sedentary (<600MET-min/week).
Exclusion Criteria:
- Bundle branch block or pacemaker rhythm
- Limitation or contraindication to moderate physical activity (fast walking)
- Unstable clinical situation
- Communication difficulties due to language or sensorial deficiencies.
- Lack of informed consent
Study Plan
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
NO_INTERVENTION: Control
|
Patients on control group will receive usual assistance, including physical activity counselling by their treating physician.
|
|
EXPERIMENTAL: Health coaching
|
Coaching based advice will be performed by previously trained nurses.
Intervention will be directed to increase physical activity to achieve levels recommended on guidelines.
Patients will receive one session per month during 6 months.
Time for each session is estimated on 10 to 20 minutes.
Sessions will be mostly carried out by phone, although physical attendance or internet services can also be used.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Patients achieving recommended physical activity (>600 MET-minute/week)
Time Frame: 6 months
|
Physical activity will be measured using the International Physical Activity Questionnaire (IPAQ)
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Cost-efficacy of coaching
Time Frame: 6 months
|
Cost-efficacy will be measured using SF-12v2 quality of life questionnaire
|
6 months
|
|
Improvement on functional capacity
Time Frame: 6 months
|
Exercise treadmill Bruce test will be used to assess cardiovascular fitness and compare functional capacity before and after intervention
|
6 months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Joan R Guma, Corporación Parc Taulí
Study record dates
Study Major Dates
Study Start
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PI08/90182
- CIR08/034 (OTHER_GRANT: Institut Universitari Parc Taulí. Esfera UAB)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Coronary Disease
-
Scitech Produtos Medicos SANot yet recruitingCoronary Artery Disease (CAD) | Multivessel Coronary Artery Disease | Complex Coronary Lesions | Calcific Coronary Arteriosclerosis | Small Vessel Ischemic Disease | Stenosis CoronaryBrazil
-
OPCI Core Laboratories LLCNot yet recruitingCoronary Artery Disease (CAD) | Coronary Calcification | Coronary Calcified Disease | Coronary Calcified NodulesUnited States
-
Shunmei MedicalNot yet recruitingCalcified Coronary Artery Disease | Coronary Arterial DiseasePoland, France, Spain
-
Kaohsiung Veterans General Hospital.CompletedChronic Coronary Syndrome; Coronary Artery Disease; Percutaneous Coronary InterventionTaiwan
-
University of GalwayNot yet recruitingMyocardial Ischemia | Percutaneous Coronary Intervention | Chronic Coronary Syndrome | Coronary Computed Tomography Angiography | Acute Coronary Syndromes (ACS) | Coronary Arteries Disease
-
Peking Union Medical College HospitalNot yet recruitingCoronary Artery Disease | Percutaneous Coronary Intervention | Coronary Stenosis | Coronary Restenosis | Coronary Artery Disease Progression | Coronary Stent Occlusion | Myocardial Revascularization
-
SUK MIN SEODaewoong Pharmaceutical Co. LTD.RecruitingCoronary Artery Disease (CAD) | Acute Coronary Syndromes (ACS)South Korea
-
Olivier F. BertrandRecruitingBifurcation Coronary Disease | Restenosis, Coronary | Coronary Arterial Disease (CAD)Canada
-
Ceric SàrlEuropean Cardiovascular Research Center; Philips Medical SystemsNot yet recruitingStable Coronary Artery Disease | Acute Coronary Syndromes
-
Cardiocentro TicinoNot yet recruitingMultivessel Coronary Artery Disease | Coronary Vessel | Acute Coronary Syndromes (ACS) | Vulnerable Coronary Plaques | Coronary Arterial Disease (CAD)Switzerland
Clinical Trials on Health coaching
-
Mayo ClinicRecruitingWellbeingUnited States
-
Habit DesignUniversity of Washington; TriHealth Inc.Recruiting
-
University of California, San FranciscoKaiser PermanenteCompleted
-
Pack HealthGlaxoSmithKline; University of WashingtonRecruitingMultiple Myeloma | Relapsed Hematologic MalignancyUnited States
-
Kansas State UniversityUnknown
-
Food and Health Bureau, Hong KongRecruiting
-
Chinese University of Hong KongRecruitingCardiovascular Diseases | Metabolic Diseases | CoachingHong Kong
-
Indonesia UniversityCompletedThe Effectiveness of "CARE Coaching Model" as an Effort to Empower Type 2 Diabetes Mellitus PatientsDiabetes Type 2Indonesia
-
University of California, Los AngelesCompletedHypertension | Obesity | Sedentary Lifestyle | PreDiabetes | Lifestyle-related ConditionUnited States